Perfil
Yan Li is the founder and the President of AIH LLC, which was founded in 2016.
Dr. Li is currently the Chief Executive Officer & Director at ExonanoRNA Therapeutics, Inc. since 2021 and the Director & Neurosurgeon at Minimally Invasive Brain & Spine Institute since 2020.
Dr. Li previously served as an Independent Director at Edoc Acquisition Corp.
from 2022 to 2024.
Dr. Li holds a doctorate degree from Peking Union Medical College.
Cargos activos de Yan Li
| Empresas | Cargo | Inicio |
|---|---|---|
| Minimally Invasive Brain & Spine Institute | Director/Miembro de la Junta | 01/07/2020 |
ExonanoRNA Therapeutics, Inc.
 ExonanoRNA Therapeutics, Inc. BiotechnologyHealth Technology ExonanoRNA Therapeutics, Inc. is an American company that specializes in RNA Nanotechnology, RNA DNA, and Exosome Research. The private company's focus is on developing innovative solutions in these areas. Yan Li has been the CEO of the company since 2021. | Director Ejecutivo | 01/08/2021 |
| AIH LLC | Fundador | 01/12/2016 |
Antiguos cargos conocidos de Yan Li.
| Empresas | Cargo | Fin |
|---|---|---|
| EDOC ACQU | Director/Miembro de la Junta | 21/03/2024 |
Formación de Yan Li.
| Peking Union Medical College | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Edoc Acquisition Corp.
 Edoc Acquisition Corp. Financial ConglomeratesFinance Edoc Acquisition Corp. is a blank check company, which engages in a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 20, 2020 and is headquartered in Victor, NY. | Finance |
| Minimally Invasive Brain & Spine Institute | |
ExonanoRNA Therapeutics, Inc.
ExonanoRNA Therapeutics, Inc. BiotechnologyHealth Technology ExonanoRNA Therapeutics, Inc. is an American company that specializes in RNA Nanotechnology, RNA DNA, and Exosome Research. The private company's focus is on developing innovative solutions in these areas. Yan Li has been the CEO of the company since 2021. | Health Technology |
| AIH LLC |
- Bolsa de valores
- Insiders
- Yan Li
